Ninepoint Partners’s MetLife MET Stock Holding History

Ninepoint Partners’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-6,158	Closed	-$446K	–	94
2022 Q4	$446K	Buy	+6,158	New	+$441K	0.06%	53
2019 Q2	–	Sell	-4,586	Closed	-$195K	–	108
2019 Q1	$195K	Buy	+4,586	New	+$203K	0.04%	86

Other funds holding MET

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Ninepoint Partners's MET Position: Q1 2023 in Review

Ninepoint Partners sold out of MetLife (MET) in Q1 2023, closing a stake of 6,158 shares — an estimated $446K sold.

Ninepoint Partners first reported a position in MET in Q1 2019 and held it in 2 quarters. The position peaked at $446K in Q4 2022. 1,213 funds tracked by Wall St. Rank hold MET as of Q1 2023.

Ninepoint Partners reported no remaining MetLife position as of Q1 2023 after selling out during the quarter.
Ninepoint Partners sold 6,158 MetLife shares in Q1 2023, an estimated $446K.
Ninepoint Partners first reported a position in MetLife in Q1 2019 and held it in 2 quarters.
Ninepoint Partners's MetLife position peaked at $446K in Q4 2022.
1,213 funds tracked by Wall St. Rank held MetLife as of Q1 2023.

Based on Ninepoint Partners's 13F filing for Q1 2023, filed 4 May 2023.